- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Toshiba launches CAC scoring for Aquilion
Toshiba America Medical Systems has introduced a coronary artery calcium scoring (CACS) package for its helical CT system, Aquilion. The package includes Toshiba’s FDA-cleared ECG-Gating System and Minneapolis, MN-based Vital Images’ Vitrea
Toshiba America Medical Systems has introduced a coronary artery calcium scoring (CACS) package for its helical CT system, Aquilion. The package includes Toshibas FDA-cleared ECG-Gating System and Minneapolis, MN-based Vital Images Vitrea visualization package, with the VScore calcium scoring option, which Toshiba has licensed. Toshibas CACS program first collects a 0.3-second partial scan with ECG-Gating System on Aquilion, reducing motion and artifacts. VScore is then used to evaluate a patients level and volume of arterial calcium.
The package is Toshibas latest offering in a series of CT upgrades. In September 1998, it introduced Aquilion, almost concurrently with GEs launch of its multislice CT LightSpeed QX/i scanner (SCAN 9/16/98). A few months later, the Tustin, CA, company launched Asteion, a lower priced scanner line that also supports multislice imaging, at the European Congress of Radiology in Vienna (SCAN 3/3/99).
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
